CCEL
CryoCell International Inc
4.40$
+3.5%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +212.0% | +2.8% | +14.6% | -6.7% | +18.6% | +33.9% | -6.4% | +8.2% | +4.0% | -32.6% | -8.9% | |
| – | -36.0% | +18.8% | -19.8% | +38.0% | +26.5% | +58.5% | +108.6% | +36.4% | -5.5% | -40.3% | +33.9% | |
| – | +49.2% | +193.9% | -45.2% | -50.8% | -16.9% | +56.4% | -51.5% | +53.0% | +77.0% | -4.3% | -46.6% | |
| – | -355.9% | – | -94.6% | +1,294.3% | -62.9% | -70.5% | -208.8% | – | – | – | – | |
| – | – | -17.4% | +79.9% | -12.4% | -6.1% | +64.7% | +29.3% | -12.5% | +40.8% | -38.2% | -23.3% | |
| – | -10.0% | +216.2% | -71.3% | +557.1% | +2.5% | -32.1% | +1,444.8% | +147.0% | -55.5% | -52.8% | -93.6% | |
| – | -283.9% | -48.6% | – | -12,228.4% | -93.9% | – | -2,044.5% | +119.8% | -46.7% | -40.1% | -80.0% | |
| – | – | – | – | – | – | – | – | – | -100.0% | – | +59.9% | |
| – | +20.0% | +237.1% | -95.9% | – | -680.5% | – | -708.2% | +629.8% | -56.1% | +78.2% | -88.1% | |
| – | +0.0% | – | -128.6% | – | -174.0% | -24.4% | +32.3% | – | -113.0% | – | -163.3% | |
| – | +25.7% | +61.7% | -42.5% | – | -189.9% | -2.5% | -38.6% | – | -1,501.9% | -52.8% | +384.6% | |
| – | – | -174.7% | – | -108.6% | – | +662.5% | -154.9% | – | – | – | -256.2% | |
| – | +230.7% | -2.1% | +21.0% | -16.6% | +20.8% | +41.6% | -87.8% | -981.7% | – | +87.9% | +118.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.